Human ATXN7L3 activation kit by CRISPRa

CAT#: GA111309

ATXN7L3 CRISPRa kit - CRISPR gene activation of human ataxin 7 like 3



  See Other Versions

CNY 12255.00


货期*
4周

规格
    • 1 kit

Product images

推荐一起购买 (3)
ATXN7L3 rabbit polyclonal antibody
    • 100 ul

CNY 1999.00
CNY 3280.00


ATXN7L3 (Myc-DDK-tagged)-Human ataxin 7-like 3 (ATXN7L3), transcript variant 1
    • 10 ug

CNY 3656.00
CNY 3990.00


ATXN7L3 rabbit polyclonal antibody
    • 25 ul

CNY 800.00
CNY 1280.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol ATXN7L3
Locus ID 56970
Kit Components

GA111309G1, ATXN7L3 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA111309G2, ATXN7L3 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA111309G3, ATXN7L3 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Reference Data
RefSeq NM_001098833, NM_020218
Synonyms DKFZp761G2113
Summary Component of the transcription regulatory histone acetylation (HAT) complex SAGA, a multiprotein complex that activates transcription by remodeling chromatin and mediating histone acetylation and deubiquitination. Within the SAGA complex, participates in a subcomplex that specifically deubiquitinates both histones H2A and H2B (PubMed:18206972, PubMed:21746879). The SAGA complex is recruited to specific gene promoters by activators such as MYC, where it is required for transcription. Required for nuclear receptor-mediated transactivation. Within the complex, it is required to recruit USP22 and ENY2 into the SAGA complex (PubMed:18206972). Regulates H2B monoubiquitination (H2Bub1) levels. Affects subcellular distribution of ENY2, USP22 and ATXN7L3B (PubMed:27601583).[UniProtKB/Swiss-Prot Function]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...